Stockreport

Purple Biotech to Present Data for its Lead Oncology Drug CM24 at the AACR Special Conference on Advances in Pancreatic Cancer Research

Purple Biotech Ltd. - American Depositary Shares  (PPBT) 
PDF REHOVOT, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) --  Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing f [Read more]